-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LZD5vEDNzpQ4GMkrZfIJYd+RncjZFRUaJBnrdk334r4rZMAGtTZM8v7xhgPKMLIk lPNJ+/uShNutNtK7GpbW8w== 0001448788-08-000017.txt : 20081126 0001448788-08-000017.hdr.sgml : 20081126 20081126154804 ACCESSION NUMBER: 0001448788-08-000017 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20080908 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20081126 DATE AS OF CHANGE: 20081126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. CENTRAL INDEX KEY: 0000806592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562416925 FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 033-10456 FILM NUMBER: 081217911 BUSINESS ADDRESS: STREET 1: 6 YOUPENG ROAD CITY: QUFU, SHANDONG STATE: F4 ZIP: 273100 BUSINESS PHONE: (86) 537-4424999 MAIL ADDRESS: STREET 1: 6 YOUPENG ROAD CITY: QUFU, SHANDONG STATE: F4 ZIP: 273100 FORMER COMPANY: FORMER CONFORMED NAME: NETWORK USA INC DATE OF NAME CHANGE: 20000731 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC RESOURCES INC DATE OF NAME CHANGE: 19870605 8-K/A 1 suwnfrm8k-a.htm 8-K/A AMENDMENT NO.1 FOR SEPTEMBER 8, 2008 suwnfrm8k-a.htm
 



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________

FORM 8-K/A
___________

CURRENT REPORT

Pursuant to Section 13 OR 15(D) OF The Securities Exchange Act of 1934

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):   September 8, 2008

SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)

Nevada
033-10456
56-2416925
(STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)
(COMMISSION FILE NO.)
(IRS EMPLOYEE IDENTIFICATION NO.)

6 Youpeng Road, Qufu, Shandong, China
273100
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
(Zip Code)

 
Registrant’s telephone number, including area code: (86)537 4424999

Not applicable
(FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

[ ]           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

 

 

 
 

 

 
This Current Report on Form 8-K/A (the "Amended 8-K") is being filed to include the pro forma financial information required by Item 9.01(b) of the Form 8-K previously filed by the Registrant on September 8, 2008 (the “8-K”) and to include amendments to agreements included in the Form 8-K.

 
ITEM 1.01  
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

ITEM 2.01  
COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.

As previously disclosed, on June 30, 2008, QuFu Natural Green Engineering Co., Ltd., (“Qufu Natural Green”) a wholly owned subsidiary of Sunwin International Neutraceuticals, Inc. ("Sunwin" or the “Company”) entered into an Acquisition Agreement (the “Acquisition Agreement”) with Qufu Shengwang Stevia Biology and Science Co., Ltd., (“Qufu Shengwang”) and its shareholder Shandong Shengwang Group Co., Ltd., a limited liability company organized under the laws of the People’s Republic of China (“Shandong Group”).

Under the terms of the Acquisition Agreement, Qufu Natural Green agreed to acquire Shandong Group’s 60% interest in Qufu Shengwang for a price of $7,016,200 payable in cash at closing (the “Qufu Shengwang Acquisition”). Shandong Group is owned by Laiwang Zhang, the Company’s president and its chairman of the board of directors. The purchase price under the Agreement represents 60% of the value of the net tangible assets of Qufu Shengwang of $11,693,666, as of April 30, 2008.

As previously disclosed, on September 2, 2008, Qufu Natural Green amended its June 30, 2008 Acquisition Agreement (the “Amendment to Acquisition Agreement”) with Qufu Shengwang and Shandong Group. Under the terms of the Amendment to Acquisition Agreement, Qufu Natural Green agreed to acquire Shandong Group's 60% interest in Qufu Shengwang for $6,200,413 payable in cash at closing. The purchase price represented 60% of the revised value of the net tangible assets of Qufu Shengwang of $10,334,022 as of April 30, 2008.  Qufu Shengwang's net tangible assets were reduced from $11,693,666 to $10,334,022 as a result of the application of generally accepted accounting principles in the United States (“U.S. GAAP”) which required the elimination of the difference between the fair market value and cost basis of the land use rights recorded by Qufu Shengwang in its financial statements prior to completion of an audit of its financial statements as of April 30, 2008.

On November 18, 2008, Qufu Natural Green amended the June 30, 2008 Agreement with Qufu Shengwang and its shareholder, Shandong Group (the “Second Amendment to Acquisition Agreement”). Under the terms of the Second Amendment to Acquisition Agreement, Qufu Natural Green agreed to acquire Shandong Group's 60% interest in Qufu Shengwang for $4,026,851. The purchase price represents 60% of the revised value of the net assets of Qufu Shengwang of $6,711,418 as of April 30, 2008.  The net assets of Qufu Shengwang were further revised to account for a $698,115 decrease in the value of inventory and a $2,924,489 decrease in the value of intangible assets as of April 30, 2008.

Item 3.02  
UNREGISTERED SALES OF EQUITY SECURITIES.

As previously disclosed on June 30, 2008, the Company entered into a Stock Sale and Purchase Agreement (“Stock Sale Agreement”) with Shandong Group to purchase up to 29,000,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) at a price of $.25 per share upon completion of the Qufu Shengwang Acquisition (the “Stock Sale Agreement”).  

As previously disclosed, as a result of the Amendment to Acquisition Agreement, on September 2, 2008, the Company entered into an Amendment to the Stock Sale Agreement to sell up to 29,525,776 Shares to Shandong Group at a price of $.21 per share upon completion of the Qufu Shengwang Acquisition (the “Amendment to Stock Sale Agreement”).  In addition, the Amendment to Stock Sale Agreement provides that in the event Qufu Shengwang does not earn a minimum of $5,000,000 in net income as determined in accordance with U.S. GAAP (the "Target Amount") over a period of 36 consecutive months beginning the first day of the month following the closing of the Qufu Shengwang Acquisition (the "Earnings Target Period"), Shandong Group is obligated to return a number of Shares equal to an amount computed by multiplying (i) a fraction, the numerator of which is the Target Amount less the amount of Qufu Shengwang's net income earned over the Earnings Target Period and the denominator is the Target Amount; by (ii) the number of Shares Stock purchased by Shandong Group under the Stock Sale Agreement.


 
- 1 - -

 

As a result of the Second Amendment to Acquisition Agreement, on November 18, 2008, the Company entered into a second amendment to the Stock Sale Agreement to reduce the total number of Shares to be purchased by Shandong Group from 29,525,776 to 19,175,480 at a price of $.21 per share (the “Second Amendment to Stock Sale Agreement”). As a result of the Second Amendment to Stock Sale Agreement, the Company will cancel 10,350,296 Shares issued to Shandong Group and refund to Shandong Group $2,173,562 reflecting the difference between the purchase price of $6,200,413 under the Amendment to Stock Sale Agreement and the purchase price of $4,026,851 for the Shares under the Second Amendment to the Stock Sale Agreement.  The 19,175,480 Shares purchased by Shandong Group represents approximately 22% of the issued and outstanding shares of common stock of the Company prior to the transaction.

Item 8.01
Other Events

Following is a brief discussion regarding the business and operations of Qufu Shengwang:

Overview

Qufu Shengwang Stevia Biology and Science Co., Ltd. (“Qufu Shengwang”) is a Chinese limited liability company formed in August 2007 as a foreign invested entity by Shandong Group and Korea Stevia Co., Ltd. (“Korea Stevia”).

Qufu Shengwang manufactures, sells and distributes stevioside based animal feed additives and fertilizers.  Stevioside is a 100% natural sweetener extracted from the leaves of the stevia rebaudiana plant, a green herb plant of the Aster/Chrysanthemum family.  Qufu Shengwang sells products in the provinces of Shandong, Heilongjia, and Liaoning in China to farmers of vegetables, fruits, flowers, and livestock.

Employees

Qufu Shengwang has 47 fulltime employees working in the following departments.

Department
 
Amount
     
Management
 
1
Sales
 
20
Production
 
19
Accounting
 
2
Administration
 
5
Total
 
47

Property

Qufu Shengwang operates from its 88,000 square-foot plant located at 6 Shengwang Ave, Shuyuan Economic Zone of Qufu City, Shangdong Province, China.  The facility, owned by Qufu Shengwang, includes 24,500 square-feet of manufacturing space, a 35,000 square foot warehouse, and 29,000 square feet of office space.  The facility has an annual production capacity of 500 metric tons of fertilizers and animal feeds.  Qufu Shengwang occupies this facility pursuant to land use rights which expire in March 2054.  Qufu Shengwang acquired the land use right in February 2008 which is valued at $2,315,675 (RMB 16,200,000), based on the exchange rate as of April 30, 2008).

Management

Jeong Ill-Hwan, General Manager

Mr. Jeong Ill-Hwan, 45, serves as General Manager of Qufu Shengwang since it was established in August 2007.  Mr. Ill-Hwan is also the founder and Chairman of Korea Stevia, the 40% shareholder of Qufu Shengwang. Korea Stevia was founded in February 2001 and focuses on stevia-based food additives, agricultural fertilizers, and feed additives for livestock and aquatic species.  From 1996 to 2000, Mr. Jeong Ill-Hwan was General Manager of Sei Shin Tech. Co., Ltd. that is a supplier of agricultural and livestock equipment.  From 1992 to 1995, Mr. Ill-Hwan was the director of the fiber trading department for Dai Keong Trading Co., Ltd.  Mr. Ill-Hwan obtained an Associate Degree in business administration with a concentration in agriculture and livestock in 2002 from Konkuk University, Seoul, Korea.


 
- 2 - -

 

Certain Relationships and Related Party Transactions

On February 20, 2008, Shandong Group entered into an agreement with Korea Stevia whereby Korea Stevia guaranteed the value of certain inventory it contributed to the capital of Qufu Shengwang in connection with its formation.  The inventory guarantee agreement provides that in the event Qufu Shengwang is unable to sell the inventory Korea Stevia contributed to Qufu Shengwang or the sale price of such inventory is less than $362,782 (the “Guarantee Amount”), Korea Stevia will pay Qufu Shengwang the difference between the sales amount and the Guarantee Amount. Korea Stevia owns a 40% interest in Qufu Shengwang.

Financial Statements and Exhibits

(a)
Financial statements of businesses acquired.

Included in this Current Report on Form 8-K/A are the audited financial statements of Qufu Shengwang for the period from August 20, 2007 (inception) to April 30, 2008 and the unaudited financial statements for the three months ended July 31, 2008.

(b)
Pro forma financial information.

The following pro forma financial information for the Company as required by Article 11 of Regulation S-X is filed herewith:

 
Pro forma Combined Balance Sheet at July 31, 2008 (unaudited)
 
Pro forma Combined Statement of Operations for the three months ended July 31, 2008 (unaudited), and
 
Pro forma Combined Statement of Operations for the fiscal year ended April 30, 2008.
 
The following exhibits are filed with this Current Report.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC.  
       
Date: November 26, 2008
By:
/s/ Dongdong Lin  
    Name: Dongdong Lin   
    Title: President   
       

 
 
- 3 - -

 

QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.

INDEX TO FINANCIAL STATEMENTS






 
Report of Independent Registered Public Accounting Firm
 
F-2
     
Financial Statements:
   
     
Balance Sheets
 
F-3
     
Statements of Operations
 
F-4
     
Statement of Members’ Equity
 
F-5
     
Statements of Cash Flows
 
F-6
     
Notes to Financial Statements
 
F-7 to F-19


 
 
F-1

 

INDEPENDENT AUDITORS' REPORT

To the Members and Directors
Qufu Shengwang Biology and Science Co., Ltd.

We have audited the accompanying balance sheet of Qufu Shengwang Stevia Biology and Science Co., Ltd. (“Qufu Shengwang”) as of April 30, 2008, and the related statements of operations, members’ equity and cash flows for the period from August 20, 2007 (inception) to April 30, 2008. These financial statements are the responsibility of Qufu Shengwang’s management.  Our responsibility is to express an opinion on these financial statements based on our audit.

We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Qufu Shengwang as of April 30, 2008, and the results of its operations and its cash flows for the period from August 20, 2007 (inception) to April 30, 2008 in conformity with accounting principles generally accepted in the United States of America.

 
     
       
 
By:
/s/  Sherb & Co., LLP   
    Certified Public Accountants  
 
Boca Raton, Florida
November 19, 2008
     
       



 


 
 
F-2

 



QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
 
BALANCE SHEETS
 
             
   
July 31, 2008
   
April 30, 2008
 
   
(Unaudited)
       
ASSETS
           
CURRENT ASSETS:
           
    Cash
  $ 491,706     $ 605,553  
    Accounts receivable
    7,860       -  
    Inventories, net
    750,536       663,556  
    Consumption taxes receivable
    36,976       36,993  
                 
        Total Current Assets
    1,287,078       1,306,102  
                 
PROPERTY AND EQUIPMENT (net of accumulated depreciation)
    3,424,928       3,405,630  
INTANGIBLE ASSETS (net of accumulated amortization)
    2,355,927       2,315,675  
                 
        Total Assets
  $ 7,067,933     $ 7,027,407  
                 
LIABILITIES AND MEMBERS' EQUITY
               
                 
CURRENT LIABILITIES:
               
    Accounts payable and accrued expenses
  $ 229,381     $ 315,989  
                 
MEMBERS' EQUITY:
               
    Paid-in capital
    6,356,442       6,356,442  
    Retained earnings
    (47,085 )     (20,388 )
    Other comprehensive income - foreign currency
    529,195       375,364  
        Total Members' Equity
    6,838,552       6,711,418  
                 
        Total Liabilities and Members' Equity
  $ 7,067,933     $ 7,027,407  
                 
See notes to financial statements
 


 
 
F-3

 



QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
 
STATEMENTS OF OPERATIONS
 
             
         
 
 
   
For the Three Months Ended July 31, 2008
   
For the Period From
August 20, 2007 (Inception)
to April 30, 2008
 
   
(Unaudited)
       
             
NET REVENUES
  $ 98,022     $ -  
COST OF REVENUES
    63,398       -  
GROSS PROFIT
    34,624       -  
                 
OPERATING EXPENSES:
               
     Selling expenses
    7,166       2,388  
     General and administrative
    55,189       20,502  
        Total Operating Expenses
    62,355       22,890  
                 
LOSS FROM OPERATIONS
    (27,731 )     (22,890 )
                 
INTEREST INCOME
    1,034       2,502  
                 
NET LOSS
    (26,697 )     (20,388 )
                 
OTHER COMPREHENSIVE INCOME:
               
   Unrealized foreign currency translation gain
    153,831       375,364  
                 
COMPREHENSIVE INCOME
  $ 127,134     $ 354,976  
                 
See notes to financial statements
 



 
 
F-4

 



QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
 
STATEMENT OF MEMBERS' EQUITY
 
                         
               
Other
   
Total
 
   
Paid-in
   
Retained
   
Comprehensive
   
Members'
 
   
Capital
   
Earnings
   
Loss
   
Equity
 
                         
Balance, August 20, 2007 (inception)
   $ -      $ -      $ -      $ -  
                                 
Initial Investment
    6,356,442                       6,356,442  
                                 
Net loss
            (20,388 )             (20,388 )
Foreign currency translation adjustment
                    375,364       375,364  
   Comprehensive (loss) income                              354,976   
                                 
Balance, April 30, 2008
    6,356,442       (20,388 )     375,364       6,711,418  
                                 
Net loss (unaudited)
            (26,697 )             (26,697 )
Foreign currency translation adjustment (unaudited)
                    153,831       153,831  
  Comprehensive (loss) income                              127,134  
                                 
Balance, July 31, 2008 (unaudited)
   $ 6,356,442      $ (47,085 )    $ 529,195      $ 6,838,552  
                                 
See notes to financial statements
 


 
 
F-5

 



QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
 
STATEMENTS OF CASH FLOWS
 
             
             
   
For the Three Months Ended July 31, 2008
   
For the Period From August 20, 2007 (Inception) to April 30, 2008
 
   
(Unaudited)
       
             
CASH FLOWS FROM OPERATING ACTIVITIES:
           
Net loss
  $ (26,697 )   $ (20,388 )
Adjustments to reconcile net income to net cash provided by
               
(used in) operating activities:
               
Depreciation expense
    61,105       56,619  
Amortization
    12,792       -  
Changes in assets and liabilities:
               
Accounts receivable and other receivable
    (7,788 )     -  
Inventories
    (71,096 )     (291,639 )
Accounts payable and accrued expenses
    (93,011 )     298,316  
Taxes payable
    859       (34,924 )
                 
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES
    (123,836 )     7,984  
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Capital expenditures
    (2,753 )     -  
                 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Cash portion of initial capital investment
    -       563,701  
                 
EFFECT OF EXCHANGE RATE ON CASH
    12,742       33,868  
                 
NET (DECREASE) INCREASE IN CASH
    (113,847 )     605,553  
                 
CASH  - beginning of period
    605,553       -  
                 
CASH - end of period
  $ 491,706     $ 605,553  
                 
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
               
Non-cash capital contribution
               
Inventories
  $ -     $ 334,805  
Property and equipment
  $ -     $ 3,271,775  
Intangible assets
  $ -     $ 2,186,161  
                 
See notes to financial statements
 



 
 
F-6

 
QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
NOTES TO FINANCIAL STATEMENTS



NOTE 1-ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Company

Qufu Shengwang Stevia Biology and Science Co., Ltd. (“Qufu Shengwang”) is a Chinese limited liability company formed on August 20, 2007 in the People’s Republic of China (the “PRC”), as a foreign invested entity by Shandong Shengwang Group Co., Ltd. (“Shandong Group”) a limited liability company organized under the laws of the PRC and Korea Stevia Co., Ltd. (“Korea Stevia”) a company organized under the laws of Korea. Upon formation of Qufu Shengwang, the ownership interest of Shandong Group and Korea Stevia was 60% and 40% respectively. Shandong Group and Korea Stevia contributed cash, inventory, property and equipment and intangible assets at the lower of their cost or market for their respective interest in Qufu Shengwang. Total initial contribution to Qufu Shengwang is as follows:

Cash
  $ 563,701  
Inventories
    334,805  
Property and equipment
    3,271,775  
Intangible assets
    2,186,161  
    $ 6,356,442  

Qufu Shengwang manufactures, sells and distributes stevioside based animal feed additives and fertilizers.  Stevioside is a 100% natural sweetener extracted from the leaves of the stevia rebaudiana plant.  These stevioside based fertilizers and animal feed additives offer nutritional benefits.  Qufu Shengwang sells products in the provinces of Shandong, Heilongjia, and Liaoning in the PRC.

Stevioside

The leaves of the stevia rebaudiana plant have been used for centuries to sweeten bitter beverages and to make tea in the plant’s native Paraguay.  Stevia is grown commercially in Brazil, Paraguay, Uruguay, Central America, Israel, Thailand and China.  The stevia rebaudiana plant was first introduced to China in 1977 and commercial harvesting of stevia started in the mid-1980’s. There are two major species of stevia grown in China; one was cultured by Chinese researchers and another was introduced from Japan.

Stevioside Animal Feeds

Stevioside based feed additives offer high nutritional value, natural sweetener for taste and fewer calories.  In addition, livestock populations are healthier, and have stronger immunity against diseases.

Stevioside Fertilizers

Stevioside fertilizers have been used as a substitute for chemical fertilizers, in the production of grains, fruits, vegetables, herbs, and plants.  Stevioside fertilizers can improve soil fertility, enhance immunity, and discompose harmful chemicals for plants while acting as a natural pesticide.  Furthermore, the fertilizers improve crop yields, taste, and appearance as well.

Industry Segment and Geographic Information

Qufu Shengwang operates in one business segment as defined under SFAS 131, “Segment Reporting”.  The business of Qufu Shengwang is located in and operates in China.

Unaudited Financial Statements

The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The accompanying financial statements for the interim periods are unaudited and reflect all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the periods presented. The financial statements represent the operations of Qufu Shengwang. These financial statements should be read in conjunction with the financial statements for period from August 20, 2007 (inception) to April 30, 2008 (“the 2008 Period”), and notes thereto, contained in this financial statement.  The results of operations for the three months ended July 31, 2008 are not necessarily indicative of the results for the full fiscal year ending April 30, 2009.

 
 
F-7

 
QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
NOTES TO FINANCIAL STATEMENTS - Continued



Summary of Significant Accounting Policies

The financial statements have been prepared on the historical cost basis, except for the certain financial instruments.  The principal accounting policies adopted are set out below.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

Basis of Financial Statements

Qufu Shengwang maintains its records and prepares its financial statements in accordance with accounting principles generally accepted in China. Certain adjustments and reclassifications have been incorporated in the accompanying financial statements to conform to accounting principles generally accepted in the United States of America.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable consists primarily of amounts due to Qufu Shengwang from normal business activities. Qufu Shengwang maintains an allowance for doubtful accounts to reflect the expected non-collection of accounts receivable based on past collection history and specific risks identified within the portfolio.  If the financial condition of the customers were to deteriorate resulting in an impairment of their ability to make payments, or if payments from customers are significantly delayed, additional allowances might be required. Qufu Shengwang had no allowances for doubful accounts at July 31, 2008 or April 30, 2008.

Inventories

Inventories, consisting of raw materials, work in process, and finished goods related to Qufu Shengwang products, are stated at the lower of cost or market utilizing weighted average method.

Value Added Taxes (VAT)

The Company is required to charge and to collect for value added taxes (consumption taxes payable) on their sales. In addition, the Company pays value added taxes (consumption taxes receivable) on their primary purchases, recorded as a receivable. These amounts are netted for financial statement purposes. The total consumption taxes receivable as of July 31, 2008 and April 30, 2008 was $36,976 and $36,993, respectively.

Accounts Payable

Accounts payable indicates the cost of goods which have been delivered but for which Qufu Shengwang has not been presented a bill for payment.  Certain vendors will extend extended payment terms to Qufu Shengwang. Ordinarily purchases made by Qufu Shengwang are due upon demand upon the presentation of a billing statement.  None of the amounts are due to a related party.

Accounts payable and accrued expenses were $315,989 as of April 30, 2008.  As of July 31, 2008, accounts payable and accrued expenses were $229,381.  Such liabilities as of July 31, 2008 and April 30, 2008 included operating payables and other accrued expenses.

Property and Equipment

Property and equipment are stated at cost.  Depreciation and amortization are provided using the straight line method over the estimated economic lives of the assets, which are from five to thirty years.  Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized.  Expenditures for maintenance and repairs are charged to expense as incurred.  In accordance with Statement of Financial Accounting Standards (“SFAS”) No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets”, Qufu Shengwang examines the possibility of decreases in the value of fixed assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.

 
 
F-8

 
QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
NOTES TO FINANCIAL STATEMENTS - Continued



Intangible Assets

Intangible assets consist of a land use right.  Land use right are stated at cost.  Amortization is provided using the straight line method over the estimated economic lives of the assets, which has an expiration date of March 14, 2054.

Fair Value of Financial Instruments

Statement of Financial Accounting Standards No. 107, "Disclosures about Fair Value of Financial Instruments", requires disclosures of information about the fair value of certain financial instruments for which it is practicable to estimate the value.  For purposes of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation.

The carrying amounts reported in the balance sheet for cash, accounts receivable, accounts payable and accrued expenses, loans and amounts due from related parties approximate their fair market value based on the short-term maturity of these instruments.

Revenue Recognition

Qufu Shengwang follows the guidance of the Securities and Exchange Commission's Staff Accounting Bulletin 104 and SAB Topic 13 for revenue recognition.  In general, Qufu Shengwang records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured.

Foreign Currencies

Transactions and balances in other currencies are converted into U.S. dollars in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 52, “Foreign Currency Translation”, and are included in determining net income or loss.

For foreign operations with the local currency as the functional currency, assets and liabilities are translated from the local currencies into U.S. dollars at the exchange rate prevailing at the balance sheet date.  Revenues and expenses are translated at weighted average exchange rates for the period to approximate translation at the exchange rates prevailing at the dates those elements are recognized in the financial statements.  Translation adjustments resulting from the process of translating the local currency financial statements into U.S. dollars are included in determining comprehensive income or loss.

The reporting currency is the U.S. dollar.  The functional currency of Qufu Shengwang is the local currency, the Chinese dollar or Renminbi (“RMB”).  The financial statements of Qufu Shengwang are translated into United States dollars using end of period rates of exchange for assets and liabilities, and average rates of exchange for the period for revenues, costs, and expenses.  Net gains and losses resulting from foreign exchange transactions are included in the statements of operations and were not material during the periods presented due to fluctuations between the RMB and the United States dollar.  The cumulative translation adjustment and effect of exchange rate changes on cash at April 30, 2008 was $375,364. The cumulative translation adjustment and effect of exchange rate changes on cash at July 31, 2008 was $153,831.

On July 21, 2005, the central government of China allowed the RMB to fluctuate, ending its decade old policy of valuation pegged to the U.S. dollar.  The new policy has resulted in a 2% approximate increase in value against the U.S. dollar.  Historically the Chinese government has benchmarked the RMB exchange ratio against the U.S. dollar, thereby mitigating the associated foreign currency exchange rate fluctuation risk.  Qufu Shengwang does not believe that its foreign currency exchange rate fluctuation risk is significant, especially if the Chinese government continues to benchmark the RMB against the U.S. dollar.

Income Tax

Income tax expense is based on reported income before income tax.  Deferred income tax reflect the effect of temporary differences between asset and liability amounts that are recognized for financial reporting purposes and the amounts that are recognized for income tax purposes.  These deferred taxes are measured by applying currently enacted tax laws.  Valuation allowances are recognized to reduce the deferred tax assets to the amount that is more likely than not to be realized.  In assessing the likelihood of realization, management considers estimates of future taxable income.

 
 
F-9

 
QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
NOTES TO FINANCIAL STATEMENTS - Continued



Comprehensive Income

Qufu Shengwang uses Statement of Financial Accounting Standards No. 130 (“SFAS 130”) "Reporting Comprehensive Income".  Comprehensive income is comprised of net income and all changes to the statements of members' equity, except those due to investments by members, changes in members’ equity and distributions to members.  For Qufu Shengwang, comprehensive income for the 2008 Period and the three months ended July 31, 2008 included net loss and foreign currency translation adjustments.

NOTE 2-INVENTORIES

Inventories consisted of the following:

   
July 31, 2008
   
April 30, 2008
 
   
(unaudited)
       
Raw materials
  $ 31,110     $ 27,969  
Work in process
    335,217       240,147  
Finished goods
    21,427       40,800  
Finished goods (from Korea Stevia)
    362,782       354,640  
    $ 750,536     $ 663,556  

On February 20, 2008, Shandong Group entered into an agreement with Korea Stevia whereby Korea Stevia guaranteed the value of certain inventory (the “inventory guarantee”) it contributed to the initial capital of Qufu Shengwang in connection with the formation of Qufu Shengwang. The inventory guarantee provides that in the event Qufu Shengwang is unable to sell the inventory Korea Stevia contributed to Qufu Shengwang or the sale price of such inventory is less than $362,782 (the “Guarantee Amount”), Korea Stevia will pay Qufu Shengwang the difference between the sales amount and the Guarantee Amount. The inventory as of April 30, 2008 and July 31, 2008 reflects the market value for all inventory including the finished goods inventory from Korea Stevia.

NOTE 3-PROPERTY AND EQUIPMENT

Property and equipment consisted of the following:

 
Estimated Life
 
July 31, 2008
   
April 30, 2008
 
     
(unaudited)
       
Buildings
10-30 years
  $ 1,490,359     $ 1,456,912  
Auto and Trucks
5 years
    38,694       37,827  
Manufacturing Equipment
5-10 years
    1,997,076       1,949,542  
Office Equipment
5-10 years
    21,813       21,323  
        3,547,942       3,465,604  
Less: Accumulated Depreciation
      (123,014 )     (59,974 )
      $ 3,424,928     $ 3,405,630  

For the 2008 Period, depreciation expense amounted to $56,619.  For the three month period ended July 31, 2008, depreciation expense amounted to $61,105.


 
 
F-10

 
QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
NOTES TO FINANCIAL STATEMENTS - Continued


NOTE 4-INTANGIBLE ASSETS

Intangible assets consisted of the following:

 
Estimated Life
 
July 31, 2008
   
April 30, 2008
 
     
(unaudited)
       
Land Use Right
46 years
  $ 2,368,836     $ 2,315,675  
Less: Accumulated Amortization
      (12,909 )     -  
      $ 2,355,927     $ 2,315,675  

Qufu Shengwang acquired land use rights in February 2008 valued at $2,315,675. The land use right grants Qufu Shengwang rights to use certain properties located in China until March 14, 2054.  For the three month period ended July 31, 2008 and the 2008 Period, amortization expense amounted to $12,792 and $0, respectively.

NOTE 5-INCOME TAX

Qufu Shengwang accounts for income taxes under Statement of Financial Accounting Standards No. 109, "Accounting for Income Taxes" “SFAS 109”. SFAS 109 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and the tax basis of assets and liabilities, and for the expected future tax benefit to be derived from tax losses and tax credit carry forwards.  SFAS 109 additionally requires the establishment of a valuation allowance to reflect the likelihood of realization of deferred tax assets.

The operations of Qufu Shengwang are governed by the Income Tax Law of the People’s Republic of China concerning Foreign Investment Enterprises and Foreign Enterprises and local income tax laws (the “PRC Income Tax Law”).  Pursuant to the PRC Income Tax Law, wholly-owned foreign enterprises are subject to tax at a statutory rate of 25%.

Qufu Shenwang as a foreign invested entity in the PRC is entitled to a tax abatement for two years subsequent to their establishment under PRC Income Tax Law. Accordingly, Qufu Shenwang has not provided for any income taxes for the 2008 period and the three months ended July 31, 2008.

Qufu Shengwang may apply tax losses to future periods when income would be generated. Under PRC Income Tax Law NOL’s may be used for a period of 5 years from the date the NOL’s are generated. The total net operating losses (NOL’s) as of July 31, 2008 and April 30, 2008 is approximately $47,600 and $20,000 respectively. Accordingly, Qufu Shengwang has recorded a deferred tax asset of approximately $12,000 and $5,000 as of July 31, 2008 and April 30, 2008, respectively, to reflect the benefit of these NOL’s at the prevailing PRC income tax rate for the respective dates then ended.  These deferred tax assets have been fully reserved as of the respective dates then ended and are reflected at $-0- as of July 31, 2008 and April 30, 2008, respectively, until such time as Qufu Shengwang achieves profitable operations.

NOTE 6-RELATED PARTY TRANSACTIONS

On February 20, 2008, Shandong Group entered into an agreement with Korea Stevia whereby Korea Stevia guaranteed the value of certain inventory it contributed to the capital of Qufu Shengwang in connection with its organization. The inventory guarantee agreement provides that in the event Qufu Shengwang is unable to sell the inventory Korea Stevia contributed to Qufu Shengwang or the sale price of such inventory is less than $362,782 (the “Guarantee Amount”), Korea Stevia will pay Qufu Shengwang the difference between the sales amount and the Guarantee Amount. Korea Stevia owns a 40% interest in Qufu Shengwang.

NOTE 6-SUBSEQUENT EVENTS

As previously disclosed, on June 30, 2008, QuFu Natural Green Engineering Co., Ltd., (“Qufu Natural Green”) a wholly owned subsidiary of Sunwin International Neutraceuticals, Inc. ("Sunwin" or the “Company”) entered into an Acquisition Agreement (the “Acquisition Agreement”) with Qufu Shengwang Stevia Biology and Science Co., Ltd., (“Qufu Shengwang”) and its shareholder Shandong Shengwang Group Co., Ltd., a limited liability company organized under the laws of the People’s Republic of China (“Shandong Group”).

 
 
F-11

 
QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
NOTES TO FINANCIAL STATEMENTS - Continued



Under the terms of the Agreement, Qufu Natural Green agreed to acquire Shandong Group’s 60% interest in Qufu Shengwang for a price of $7,016,200 payable in cash at closing (the “Qufu Shengwang Acquisition”). Shandong Group is owned by Laiwang Zhang, the Company’s president and its chairman of the board of directors. The purchase price under the Agreement represents 60% of the value of the net tangible assets of Qufu Shengwang of $11,693,666, as of April 30, 2008.

As previously disclosed, on September 2, 2008, Qufu Natural Green amended its June 30, 2008 Acquisition Agreement (the “Amendment to Acquisition Agreement”) with Qufu Shengwang and Shandong Group. Under the terms of the Amendment to Acquisition Agreement, Qufu Natural Green agreed to acquire Shandong Group's 60% interest in Qufu Shengwang for $6,200,413 payable in cash at closing. The purchase price represented 60% of the revised value of the net tangible assets of Qufu Shengwang of $10,334,022 as of April 30, 2008.  Qufu Shengwang's net tangible assets were reduced from $11,693,666 to $10,334,022 as a result of the application of generally accepted accounting principles in the United States (“U.S. GAAP”) which required the elimination of the difference between the fair market value and cost basis of the land use rights recorded by Qufu Shengwang in its financial statements prior to completion of an audit of its financial statements as of April 30, 2008.

On November 18, 2008, Qufu Natural Green amended the June 30, 2008 Agreement with Qufu Shengwang and its shareholder, Shandong Group (the “Second Amendment to Acquisition Agreement”). Under the terms of the Second Amendment to Acquisition Agreement, Qufu Natural Green agreed to acquire Shandong Group's 60% interest in Qufu Shengwang for $4,026,851. The purchase price represents 60% of the revised value of the net assets of Qufu Shengwang of $6,711,418 as of April 30, 2008.  The net assets of Qufu Shengwang were further revised to account for a $698,115 decrease in the value of inventory and a $2,924,489 decrease in the value of intangible assets as of April 30, 2008.

As previously disclosed, on June 30, 2008 the Company entered into a Stock Sale and Purchase Agreement (“Stock Sale Agreement”) with Shandong Group to purchase up to 29,000,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) at a price of $.25 per share upon completion of the Qufu Shengwang Acquisition (the “Stock Sale Agreement”).  

As previously disclosed, as a result of the Amendment to Acquisition Agreement, on September 2, 2008, the Company entered into an Amendment to the Stock Sale Agreement to sell up to 29,525,776 shares of Common Stock to Shandong Group at a price of $.21 per share upon completion of the Qufu Shengwang Acquisition (the “Amendment to Stock Sale Agreement”).  In addition, the Amendment to Stock Sale Agreement provides that in the event Qufu Shengwang does not earn a minimum of $5,000,000 in net income as determined in accordance with U.S. GAAP (the "Target Amount") over a period of 36 consecutive months beginning the first day of the month following the closing of the Qufu Shengwang Acquisition (the "Earnings Target Period"), Shandong Group is obligated to return a number of Shares equal to an amount computed by multiplying (i) a fraction, the numerator of which is the Target Amount less the amount of Qufu Shengwang's net income earned over the Earnings Target Period and the denominator is the Target Amount; by (ii) the number of Shares Stock purchased by Shandong Group under the Stock Sale Agreement.

As a result of the Second Amendment to Acquisition Agreement, on November 18, 2008 the Company entered into a second amendment to the Stock Sale Agreement to reduce the total number of Shares to be purchased by Shandong Group from 29,525,776 to 19,175,480 at a price of $.21 per share (the “Second Amendment to Stock Sale Agreement”). As a result of the Second Amendment to Stock Sale Agreement, the Company will cancel 10,350,296 Shares issued to Shandong Group and refund to Shandong Group $2,173,562 reflecting the difference between the purchase price of $6,200,413 under the Amendment to Stock Sale Agreement and the purchase price of $4,026,851 for the Shares under the Second Amendment to the Stock Sale Agreement.  The 19,175,480 shares of Common Stock purchased by Shandong Group represents approximately 22% of the issued and outstanding shares of common stock of the Company prior to the transaction.

NOTE 8 - OPERATING RISK

(a) Country risk

Revenues are primarily derived from the manufacture and sale of magnesium in the People’s Republic of China ("PRC"). Therefore, a downturn or stagnation in the economic environment of the PRC could have a material adverse effect on the financial condition of Qufu Shengwang.


 
 
F-12

 
QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD.
NOTES TO FINANCIAL STATEMENTS - Continued


(b) Products risk

In addition to competing with other companies, Qufu Shengwang could have to compete with larger U.S. companies who have greater funds available for expansion, marketing, research and development and the ability to attract more qualified personnel if access is allowed into the PRC market. If U.S. companies do gain access to the PRC markets, they may be able to offer products at a lower price.  There can be no assurance that Qufu Shengwang will remain competitive should this occur.

(c) Exchange risk

Qufu Shengwang cannot guarantee that the current exchange rate will remain steady, therefore there is a possibility that Qufu Shengwang could post the same amount of profit for two comparable periods and because of a fluctuating exchange rate actually post higher or lower profit depending on exchange rate of the RMB converted to U.S. dollars on that date.  The exchange rate could fluctuate depending on changes in the political and economic environments without notice.

(d) Political risk

Currently, PRC is in a period of growth and is openly promoting business development in order to bring more business into PRC.  Additionally PRC allows a Chinese corporation to be owned by a United States corporation.  If the laws or regulations are changed by the PRC government, Qufu Shengwang’s ability to operate the PRC subsidiaries could be affected.

(e) Key personnel risk

Qufu Shengwang future success depends on the continued services of its general manager, Jeong Ill-Hwan.  . The loss of any of their services would be detrimental to Qufu Shengwang and could have an adverse effect on business development.  Future success is also dependent on the ability to identify, hire, train and retain other qualified managerial and other employees.  Competition for these individuals is intense and increasing.

 
 

 
F-13

 


UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION
JULY 31, 2008 AND APRIL 30, 2008

The unaudited pro forma Combined financial statements are presented to illustrate the estimated effects of Sunwin International Neutraceuticals, Inc. having entered into a purchase agreement with Qufu Shengwang Stevia Biology and Science Co., Ltd. On June 30, 2008, QuFu Natural Green Engineering Co., Ltd., (“Qufu Natural Green”) a wholly owned subsidiary of Sunwin International Neutraceuticals, Inc. (the “Company”) entered into an Acquisition Agreement (the “Acquisition Agreement”) with Qufu Shengwang Stevia Biology and Science Co., Ltd., (“Qufu Shengwang”) and its shareholder Shandong Shengwang Group Co., Ltd., a limited liability company organized under the laws of the People’s Republic of China (“Shandong Group”). Under the terms of the Agreement, Qufu Natural Green agreed to acquire Shandong Group’s 60% interest in Qufu Shengwang for a price of $7,016,200 payable in cash at closing (the “Qufu Shengwang Acquisition”). Shandong Group is owned by Laiwang Zhang, the Company’s president and its chairman of the board of directors. The purchase price under the Agreement represents 60% of the value of the net tangible assets of Qufu Shengwang of $11,693,666, as of April 30, 2008.

Amendment to Acquisition Agreement

On September 2, 2008, Qufu Natural Green amended its June 30, 2008 Acquisition Agreement (the “Amendment to Acquisition Agreement”) with Qufu Shengwang and its 60% shareholder, Shandong Group. Under the terms of the Amendment to Acquisition Agreement, Qufu Natural Green agreed to acquire Shandong Group's 60% interest in Qufu Shengwang for $6,200,413 payable in cash at closing. The purchase price represents 60% of the revised value of the net tangible assets of Qufu Shengwang of $10,334,022 as of April 30, 2008.  Qufu Shengwang's net assets were reduced from $11,693,666 to $10,334,022 as a result of the application of generally accepted accounting principles in the United States (“U.S. GAAP”) which required the elimination of the difference between the fair market value and cost basis of the land use rights recorded by Qufu Shengwang in its financial statements prior to completion of an audit of its financial statements as of April 30, 2008.

Second Amendment to Acquisition Agreement

On November 18, 2008, Qufu Natural Green amended the June 30, 2008 Acquisition Agreement with Qufu Shengwang and its shareholder, Shandong Group (the “Second Amendment to Acquisition Agreement”). Under the terms of the Second Amendment to Acquisition Agreement, Qufu Natural Green agreed to acquire Shandong Group's 60% interest in Qufu Shengwang for $4,026,851. The purchase price represents 60% of the revised value of the net assets of Qufu Shengwang of $6,711,418 as of April 30, 2008.  The net assets of Qufu Shengwang were revised to account for a $698,115 decrease in the value of inventory and a $2,924,489 decrease in the value of intangible assets as of April 30, 2008.

Stock Sale Agreement

On June 30, 2008, the Company entered into a Stock Sale and Purchase Agreement with Shandong Group to purchase up to 29,000,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) at a price of $.25 per share upon completion of the Qufu Shengwang Acquisition (the “Stock Sale Agreement”).  

Amendment to Stock Sale Agreement

As a result of the Amendment to Acquisition Agreement, on September 2, 2008, the Company entered into an Amendment to the Stock Sale Agreement to sell up to 29,525,776 shares of the Company’s Common Stock to Shandong Group at a price of $.21 per share upon completion of the Qufu Shengwang Acquisition (the “Amendment to Stock Sale Agreement”).  In addition, the Amendment to Stock Sale Agreement provides that in the event Qufu Shengwang does not earn a minimum of $5,000,000 in net income as determined in accordance with U.S. GAAP (the "Target Amount") over a period of 36 consecutive months beginning the first day of the month following the closing of the stock purchase (the "Earnings Target Period"), Shandong Group shall be obligated to return a number of shares of common stock equal to an amount computed by multiplying (i) a fraction, the numerator of which is the Target Amount less the amount of Qufu Shengwang's net income earned over the Earnings Target Period and the denominator is the Target Amount; by (ii) the number of shares of Common Stock purchased by Shandong Group under the Stock Sale Agreement.

Second Amendment to Stock Sale Agreement

As a result of the Second Amendment to Acquisition Agreement, on November 18, 2008 the Company entered into a second amendment to the Stock Sale Agreement to reduce the total number of shares of the Company’s Common Stock to be purchased by

 
 
F-14

 

Shandong Group from 29,525,776 to 19,175,480 at a price of $.21 per share (the “Second Amendment to Stock Sale Agreement”). As a result of the Second Amendment to Stock Sale Agreement, the Company will cancel 10,350,296 shares of its Common Stock issued to Shandong Shengwang and refund from Shandong Shengwang $2,173,562 reflecting the difference between the purchase price of $6,200,413 under the Amendment to Stock Sale Agreement and the purchase price of $4,026,851 for the shares of Common Stock under the Second Amendment to the Stock Sale Agreement.  The 19,175,480 shares of Common Stock purchased by Shandong Group represents approximately 22% of the issued and outstanding shares of common stock of the Company prior to the transaction.
 
    Qufu Shengwang Stevia Biology and Science Co., Ltd. (“Qufu Shengwang”) is a Chinese limited liability company formed in August 2007 as a foreign invested entity by Shandong Group and Korea Stevia Co., Ltd. (“Korea Stevia”). Qufu Shengwang manufactures, sells and distributes stevioside based animal feed additives and fertilizers.  Stevioside is a 100% natural sweetener extracted from the leaves of the stevia rebaudiana plant, a green herb plant of the Aster/Chrysanthemum family.  Qufu Shengwang sells products in the provinces of Shandong, Heilongjia, and Liaoning in China to farmers of vegetables, fruits, flowers, and livestock.

Qufu Shengwang Stevia Biology and Science Co., Ltd reported net revenues of $98,022 and $0, as of July 31, 2008 and April 30, 2008, respectively, and a net loss of $26,697 and $20,388 as of July 31, 2008 and April 30, 2008, respectively.

 The unaudited pro forma condensed balance sheet combines the balance sheets of the Company and Qufu Shengwang as of July 31, 2008, and gives pro forma effect to the Qufu Shengwang Acquisition and the Company's sale of the Shares pursuant to the Stock Sale Agreement as if they had occurred on July 31, 2008. The pro forma statement of operations combines the operations of the Company and Qufu Shengwang for the three months ended July 31, 2008 and for the fiscal year ended April 30, 2008 assumes that the acquisition of the 60% equity interest in Qufu Shengwang has occurred as of the reported periods. The Unaudited pro forma combined condensed financial statements are based upon the historical financial statements of the Company and Qufu Shengwang after considering the effect of the adjustments described in the footnotes that follow.

The pro forma information is presented for illustrative purposes only and is not necessarily indicative of the operating results or financial position that would have occurred had the acquisition of Qufu Shengwang by the Company occurred as of the periods presented, or during the operational periods presented, nor is it necessarily indicative of the future financial position or operating results.

These pro forma financial statements should be read in conjunction with the audited historical financial statements of the Company, and the related financial statements for Qufu Shengwang included in this Form 8-K/A.
 
A preliminary allocation of the purchase price has been made to major categories of assets and liabilities in the accompanying pro forma financial statements based on available information. The actual allocation of purchase price and the resulting effect on income from operations may differ significantly from the pro forma amounts included herein. These pro forma adjustments represent the Company’s preliminary determination of purchase accounting adjustments and are based upon available information and certain assumptions that the Company believes to be reasonable. Consequently, the amounts reflected in the pro forma financial statements are subject to change, and the final amounts may differ substantially.
 
The accompanying unaudited pro forma combined financial statements do not give effect to any cost savings, revenue synergies or restructuring costs which may result from the integration of the Company and the operations of Qufu Shengwang. Further, actual results may be different from these unaudited pro forma combined financial statements.

 

 
F-15

 

 

 
PRO FORMA COMBINED BALANCE SHEETS
 
July 31, 2008
 
(Unaudited)
 
                           
   
Sunwin
   
Qufu
   
Pro forma
     
Sunwin
 
   
International
   
Shengwang
   
Adjustments
   Footnotes*  
International
 
ASSETS
                         
                           
CURRENT ASSETS:
                         
    Cash
  $ 7,660,694     $ 491,706     $ (4,026,851 )
(1)
  $ 8,152,400  
                      4,026,851  
(3)
       
    Accounts receivable
    3,808,388       7,860                 3,816,248  
    Inventories, net
    5,013,694       750,536                 5,764,230  
    Prepaid expenses and other assets
    349,802       -                 349,802  
    Consumption taxes receivable
    -       36,976                 36,976  
        Total Current Assets
    16,832,578       1,287,078       -         18,119,656  
                                -  
PROPERTY AND EQUIPMENT
    14,188,808       3,424,928                 17,613,736  
INVESTMENT IN SUBSIDIARY
    -       -       4,026,851  
(1)
    -  
                      (4,026,851 )
(2)
       
INTANGIBLE ASSETS
    -       2,355,927       -         2,355,927  
        Total Assets
  $ 31,021,386     $ 7,067,933     $ -       $ 38,089,319  
                                   
                                   
LIABILITIES AND STOCKHOLDERS' EQUITY
                                 
                                   
CURRENT LIABILITIES:
                                 
    Note payable
  $ 100,000     $ -     $ -       $ 100,000  
    Accounts payable and accrued expenses
    2,757,071       229,381                 2,986,452  
    Advances from customers
    5,108       -                 5,108  
    Taxes payable
    85,604       -                 85,604  
    Due to related party
    431,477       -                 431,477  
        Total Current Liabilities
    3,379,260       229,381       -         3,608,641  
                                   
OTHER PAYABLES
    157,747       -       -         157,747  
        Total Liabilities
    3,537,007       229,381       -         3,766,388  
                                   
Minority Interest:
    -       -       2,735,421  
(2)
    2,735,421  
                                   
STOCKHOLDERS' EQUITY:
                                 
    Preferred stock ($.001 Par Value; 1,000,000 shares authorized;
                                 
        No shares issued and outstanding)
    -       -                 -  
    Common stock ($.001 Par Value; 200,000,000 shares authorized;
    87,007       -       19,175  
(3)
    106,182  
        87,006,936 shares issued and outstanding at July 31, 2008)
                                 
    Additional paid-in capital
    17,341,814       6,356,442       (6,356,442 )
(2)
    21,425,770  
                      76,280  
(2)
       
                      4,007,676  
(3)
       
                                   
    Retained earnings
    6,623,553       (47,085 )     47,085  
(2)
    6,623,553  
    Deferred compensation
                                 
    Subscription receivable
    (372,900 )     -                 (372,900 )
    Other comprehensive income - foreign currency
    3,804,905       529,195       (529,195 )
(2)
    3,804,905  
        Total Stockholders' Equity
    27,484,379       6,838,552       (2,735,421 )       31,587,510  
                                   
        Total Liabilities and Stockholders' Equity
  $ 31,021,386     $ 7,067,933     $ -       $ 38,089,319  
                                   
 
*Footnotes refer to proforma adjusting journal entries set forth below.
 
 
 
 
F-16

 


SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND SUBSIDIARIES
   
PRO FORMA COMBINED STATEMENTS OF OPERATIONS
   
(Unaudited)
   
                           
   
For the Three Months Ended
   
   
July 31, 2008
   
                           
     
Sunwin
International
     
Qufu
Shengwang
     
Pro forma
Adjustments
   
Sunwin
International
Pro-forma
   
                           
NET REVENUES
  $ 6,227,872     $ 98,022      $
-
    $ 6,325,894    
COST OF REVENUES
    4,717,667       63,398    
 -
      4,781,065    
GROSS PROFIT
    1,510,205       34,624       -       1,544,829    
                                   
OPERATING EXPENSES:
                                 
     Stock-based consulting expense
    123,748       -      
- 
      123,748    
     Selling expenses
    459,336       7,166             466,502    
     General and administrative
    568,168       55,189             623,357    
        Total Operating Expenses
    1,151,252       62,355       -       1,213,607    
                                   
INCOME (LOSS) FROM OPERATIONS
    358,953       (27,731 )           331,222    
                                   
OTHER INCOME :
                                 
     Other income
    240       -             240    
     Interest income
    12,611       1,034             13,645    
        Total Other Income
    12,851       1,034       -       13,885    
                                   
INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES
    371,804       (26,697 )           345,107    
                                   
INCOME TAXES
    (74,170 )     -             (74,170 )  
                                   
INCOME (LOSS) BEFORE MINORITY INTEREST
    297,634       (26,697 )     -       270,937    
                                   
MINORITY INTEREST
    -       -       10,679  (5)     10,679    
                                   
NET INCOME (LOSS)
    297,634       (26,697 )     10,679  (5)     281,616    
                                   
OTHER COMPREHENSIVE INCOME:
                                 
   Unrealized foreign currency translation gain
    615,112       153,831             768,943    
                                   
COMPREHENSIVE INCOME
  $ 912,746     $ 127,134     $ 10,679  (5)   $ 1,050,559    
                                   
NET INCOME PER COMMON SHARE - BASIC AND DILUTED:
                                 
      Net income (loss) per common share - basic
  $ 0.00                     $ 0.00    
      Net income (loss) per common share - diluted
  $ 0.00                     $ 0.00    
                                   
     Weighted Common Shares Outstanding - basic
    87,006,936                       106,182,416  (6)  
     Weighted Common Shares Outstanding - diluted
    87,006,936                       106,182,416  (6)  
 
 
F-17


 
SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND SUBSIDIARIES
 
PRO FORMA COMBINED STATEMENTS OF OPERATIONS
 
(Unaudited)
 
                       
   
 
   
 
         
 
 
   
For the Year
Ended April 30, 2008
   
For the Period From August 20, 2007 (Inception)
to April 30, 2008
         
For the Year
Ended April 30, 2008
 
                         
     
Sunwin
International
     
Qufu
Shengwang
     
Pro forma
Adjustments
   
Sunwin
International
Pro forma
 
                         
NET REVENUES
  $ 22,932,222     $ -      $
 -
    $ 22,932,222  
COST OF REVENUES
    16,846,679       -    
 -
      16,846,679  
GROSS PROFIT
    6,085,543       -       -       6,085,543  
                                 
OPERATING EXPENSES:
                               
     Stock-based consulting expense
    1,085,129       -             1,085,129  
     Selling expenses
    2,483,177       2,388             2,485,565  
     General and administrative
    2,499,794       20,502             2,520,296  
        Total Operating Expenses
    6,068,100       22,890       -       6,090,990  
                                 
INCOME (LOSS) FROM OPERATIONS
    17,443       (22,890 )           (5,447 )
                                 
OTHER INCOME :
                               
     Other income
    6,488       -             6,488  
     Interest income
    80,330       2,502             82,832  
        Total Other Income
    86,818       2,502       -       89,320  
                                 
INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES
    104,261       (20,388 )           83,873  
                                 
INCOME TAXES
    (101,682 )     -               (101,682 )
                                 
INCOME (LOSS) BEFORE MINORITY INTEREST
    2,579       (20,388 )     -       (17,809 )
                                 
MINORITY INTEREST
    -       -       8,155  (4)     8,155  
                                 
NET INCOME (LOSS)
    2,579       (20,388 )     8,155  (4)     (9,654 )
                                 
OTHER COMPREHENSIVE INCOME:
                               
   Unrealized foreign currency translation gain
    2,406,398       375,364             2,781,762  
                                 
COMPREHENSIVE INCOME
  $ 2,408,977     $ 354,976     $ 8,155  (4)   $ 2,772,108  
                                 
NET INCOME PER COMMON SHARE-BASIC AND DILUTED:
                         
                                 
      Net income (loss) per common share - basic
  $ 0.00                     $ (0.00 )
      Net income (loss) per common share - diluted
  $ 0.00                     $ (0.00 )
                                 
     Weighted Common Shares Outstanding - basic
    86,821,905                       105,997,385  (6)
     Weighted Common Shares Outstanding - diluted
    86,821,905                       105,997,385  (6)


F-18

 
 
SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND SUBSIDIARIES
 
Pro forma Ajusting Journal Entries
 
July 31, 2008
 
      (Amounts in Dollars)    
Dr.
   
Cr.
 
                   
  (1
)
Investment in Qufu Shengwang
   
4,026,851
       
       
Cash
           
4,026,851
 
        (Investment in Qufu Shengwang)                
                         
  (2
)
APIC - Qufu Shengwang
   
6,356,442
         
     
Other Comprehensive - Qufu Shengwang
   
529,195
         
     
APIC - Sunwin
           
76,280
 
       
Investment in Qufu Shengwang
           
4,026,851
 
       
Minority Interest in Qufu Shengwang
           
2,735,421
 
       
Retained Earnings - Qufu Shengwang
           
47,085
 
     
(To eliminate equity in new subsidiary Qufu Shengwang. Additional equity to Sunwin due to acquisition of Qufu Shengwang  assets as of June 30, 2008 based on April 30, 2008 net assets.)
               
                     
  (3
)
Cash
     
4,026,851
         
       
Common Stock
           
19,175
 
       
APIC
           
4,007,676
 
     
(To reflect purchase of Common Stock of Sunwin by Shandong Group.)
               
                         
  (4
)
To account for minority interest in Qufu Shengwang for the period August 20, 2007 to April 30, 2008.
 
                         
  (5
)
To account for minority interest in Qufu Shengwang for the three months ended July 31, 2008.
 
         
  (6  Includes 19,175,480 shares of the Company's Common Stock issued in connection with the acquisition of a 60% interest in Qufu Shengwang.  


 
 

 
F-19

 

EX-10.19 2 ex10-19.htm NOVEMBER 18, 2008 SECOND AMENDMENT TO ACQUISITION AGREEMENT ex10-19.htm
 


 
SECOND AMENDMENT TO ACQUISITION AGREEMENT

THIS SECOND AMENDMENT (the “Second Amendment”) is made effective as of November 18, 2008 by and between  QuFu Natural Green Engineering Co., Ltd., a limited liability company organized under the laws of the Peoples Republic of China (“Qufu Natural Green”), and Qufu Shengwang Stevia Biology and Science Co., Ltd., a limited liability company organized under the laws of the Peoples Republic of China (the “Company” or “Qufu Shengwang”), and Shandong Shengwang Group, Co., Ltd., a limited liability company organized under the laws of the Peoples Republic of China, an owner of an interest in Qufu Shengwang (“Shandong Shengwang”).  Qufu Natural Green, Qufu Shengwang and Shandong Shengwang may collectively be referred to as the “Parties”.
 
BACKGROUND
 
A. Qufu Natural Green, Qufu Shengwang and Shandong Shengwang are the parties to that certain Acquisition Agreement dated as of June 30, 2008 (the "Agreement");
 
B. The Agreement was amended as of September 2, 2008 (the “Amendment”) to adjust the Purchase Price of the Qufu Shengwang Interest to reflect a reduction in the net tangible assets of Qufu Shengwang from $11,693,666 to $10,334,022 as a result of the application of generally accepted accounting principles in the United States (“US GAAP”) required to eliminate the difference between the fair market value and cost basis of the land use rights that were recorded by Qufu Shengwang in its financial statements prior to completion of an audit to its financial statements as of April 30, 2008;
 
    C.  Subsequent to the Amendment, Qufu Shengwang adjusted its balance sheet to eliminate certain inventory in the amount of $698,115 and a patent that was included in its intangible assets valued at $2,924,489 (the “Balance Sheet Adjustments”) resulting in net tangible assets in Qufu Shengwang of $6,711,418 as of April 30, 2008; and
 
D.  As a result of the Balance Sheet Adjustments and to clarify that the reference to "net tangible assets" in the Agreement and the Amendment was intended to refer to "net assets", the parties agreed to amend certain parts of the Agreement and the Amendment as set forth below.
 
NOW, THEREFORE, in consideration of the execution and delivery of the Agreement, the Amendment and the Second Amendment and other good and valuable considera­tion, the receipt and sufficiency of which are hereby acknowl­edged, the parties hereby agree as follows:
 
1.  
Section 1 of the Amendment is hereby deleted in its entirety and replaced with the following:
 
1.              CONSIDERATION
 
Subject to the terms and conditions of this Agreement, Qufu Natural Green shall acquire the Qufu Shengwang Interest for a total consideration of $4,026,851 in cash, which amount represents 60% of the value of the net assets of Qufu Shengwang of $6,711,418 as of April 30, 2008 after giving effect to the Balance Sheet Adjustments and as determined by an independent audit prepared in accordance with generally accepted accounting principles in the United States (the “Revised Purchase Price”).  Within 20 days from the date of the Second Amendment, Shandong Shengwang agrees to refund to Qufu Natural Green the sum of $2,173,562 which represents the difference between $6,200,413 (the Purchase Price set forth in the Amendment) and $4,026,851 (the Revised Purchase Price set forth in the Second Amendment).

2.  
This Amendment shall be deemed part of, but shall take precedence over and supersede any provisions to the contrary contained in the Agreement. All initial capitalized terms used in this Amendment shall have the same meaning as set forth in the Agreement unless otherwise provided.  Except as specifically modified hereby, all of the provisions of the Agreement which are not in conflict with the terms of this Amendment shall remain in full force and effect.
 
SIGNATURE PAGE FOLLOWS
 
- 1 - -

      IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.
 
 
 Qufu Natural Green Engineering Co., Ltd.        
         
/s/ Chengxiang Yan
 
 
 
 
Name: Chengxiang Yan
       
 Title: General Manger        
         
         
 Qufu Shengwang Stevia Biology and Science Co., Ltd.
 
     Shandong Shengwang Group, Co., Ltd.  
/s/ Xia Li
   
/s/ Dongdong Lin
 
Name: Xia Li
   
Name: Dongdong Lin
 
Title: General Manager
   
Title: CEO
 

 
- 2 -
 

EX-10.20 3 ex10-20.htm NOVEMBER 18, 2008 SECOND AMENDMENT TO STOCK SALE AGREEMENT ex10-20.htm
 


SECOND AMENDMENT TO STOCK SALE AGREEMENT

THIS SECOND AMENDMENT (the “Second Amendment”) is made effective as of November 18, 2008 by and between Sunwin International Neutraceuticals, Inc., a Nevada corporation, (“Sunwin International”) and Shandong Shengwang Group Co., Ltd. a limited liability company organized under the laws of the Peoples Republic of China (“Shandong Shengwang”).  Sunwin International and Shandong Shengwang may collectively be referred to as the “Parties”.
 
BACKGROUND
 
A. Shandong Shengwang and Sunwin International are the parties to that certain Stock Sale and Purchase Agreement dated as of June 30, 2008 (the "Agreement");
 
B. The Agreement was amended as of September 2, 2008 (the “Amendment”) to adjust the Purchase Price of the Qufu Shengwang Interest to reflect a reduction in the net tangible assets of Qufu Shengwang from $11,693,666 to $10,334,022 as a result of the application of generally accepted accounting principles in the United States (“US GAAP”) required to eliminate the difference between the fair market value and cost basis of the land use rights that were recorded by Qufu Shengwang in its financial statements prior to completion of an audit to its financial statements as of April 30, 2008;
 
C.  Subsequent to the Amendment, Qufu Shengwang adjusted its balance sheet to eliminate certain inventory in the amount of $698,115 and a patent that was included in its intangible assets valued at $2,924,489 (the “Balance Sheet Adjustments”) resulting in net assets in Qufu Shengwang of $6,711,418 as of April 30, 2008; and
 
D.  As a result of the Balance Sheet Adjustments and to clarify that the reference to "net tangible assets" in the Agreement and the Amendment was intended to refer to "net assets", the parties agreed to amend certain parts of the Agreement and the Amendment as set forth below.
 
NOW, THEREFORE, in consideration of the execution and delivery of the Agreement, the Amendment and the Second Amendment and other good and valuable considera­tion, the receipt and sufficiency of which are hereby acknowl­edged, the parties hereby agree as follows:
 
1.  
Section 1 of the Amendment is hereby deleted in its entirety and replaced with the following:
 
1.              CONSIDERATION
 
(a)  Subject to the terms and conditions of this Agreement, Sunwin International shall acquire a number of shares of Sunwin International’s Common Stock (the “Revised Purchased Shares”) calculated by dividing: (i) $4,026,851, which is equal to 60% of the value of the net assets of Qufu Shengwang of $6,711,418 as of April 30, 2008 after giving effect to the Balance Sheet Adjustments and as determined by an independent audit prepared in accordance with US GAAP; by (ii) the average closing price of Sunwin International’s common stock on the OTC Bulletin Board over the 20 day period preceding the date of this Amendment which amount is $0.21 (the “Revised Purchase Price”).  Within 20 days from the date of the Second Amendment, Shandong Shengwang agrees to cancel a total of 10,350,296 shares of Sunwin International’s common stock which represents the difference between 29,525,776 (the Purchased Shares as set forth in the Amendment) and 19,175,480 (the Revised Purchased Shares provided for in the Second Amendment).  In addition, Sunwin International will refund to Shandong Shengwang the sum of $2,173,562 which represents the difference between $6,200,413 (the Purchase Price set forth in the Amendment) and $4,026,851 (the Revised Purchase Price set forth in the Second Amendment).
 
2.  
This Amendment shall be deemed part of, but shall take precedence over and supersede any provisions to the contrary contained in the Agreement. All initial capitalized terms used in this Amendment shall have the same meaning as set forth in the Agreement unless otherwise provided.  Except as specifically modified hereby, all of the provisions of the Agreement which are not in conflict with the terms of this Amendment shall remain in full force and effect.
 
SIGNATURE PAGE FOLLOWS
 

- 1 -
 
 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.
 
 Shandong Shengwang Group Co., Ltd.      Sunwin International Neutraceuticals, Inc.  
By: /s/ Xia Li
   
By: Xia Li
 
Name: Xia Li
   
Name: Xia Li
 
Title: General Manager
   
Title: General Manager
 
 
 

- 2 -
 
 

 

-----END PRIVACY-ENHANCED MESSAGE-----